000			01147nam a2200133Ia 4500
008			220620s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aAdvances in the Treatment of Renal Cell Carcinoma
546			_aEnglish[eng]
650			_arenal cell carcinoma||autophagy||hydroxychloroquine||chloroquine||ROC-325||cysteine cathepsins||cysteine cathepsin inhibitors||lysosome||renal cancer||metastatic renal cell carcinoma||immune-based combination therapies||network meta-analysis||PD-L1||predictive||biomarker||treatment||TKIs||mRCC||biomarkers||soluble factors||immunotherapy||renal cell carcinoma (RCC)||sunitib resistance||artesunate (ART)||Traditional Chinese Medicine (TCM)||growth inhibition||ferroptosis||reactive oxygen species (ROS)||clear cell renal cell carcinoma||ccRCC||RCC||kidney cancer||evolution||evolutionary trajectory||metastatic||second line therapy||renal cell cancer||immune checkpoint inhibitors||tyrosine kinase inhibitors||individualization||genomic signature||transcriptomic analysis
700			_aReynolds, Paul||Stewart, Grant D
856			_uhttps://mdpi.com/books/pdfview/book/4966
942			_cEB
999			_c28680 _d28680